Retroviral integration site selection

Viruses

Volumn 2, Issue 1, 2010, Pages 111-130

  Desfarges, Sébastien ^a   Ciuffi, Angela ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

HIV; Integrase; Integration; LEDGF; LEDGF p75; Lentivirus; PSIP1; Retrovirus; Site selection; Transcription

Indexed keywords

GAG PROTEIN; HETEROCHROMATIN PROTEIN 1; VIRUS DNA; VIRUS RNA;

AMINO TERMINAL SEQUENCE; BINDING SITE; CD4+ T LYMPHOCYTE; CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; DNA BINDING; ENDOGENOUS RETROVIRUS; ENZYME ACTIVE SITE; EPIGENETICS; GENE DUPLICATION; GENE EXPRESSION; GENE INSERTION; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; LIFE CYCLE; MACROPHAGE; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; RETROVIRUS; REVIEW; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

LENTIVIRUS;

EID: 79551637698     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v2010111     Document Type: Review

References (132)

1. Peterlin, B.M.; Trono, D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat. Rev. Immunol. 2003, 3, 97-107.
2. Goff, S.P. Host factors exploited by retroviruses. Nat. Rev. Microbiol. 2007, 5, 253-263.
3. Suzuki, Y.; Craigie, R. The road to chromatin - nuclear entry of retroviruses. Nat. Rev. Microbiol. 2007, 5, 187-196.
4. Flint, S.J.; Lynn W. Enquist, L.W.; Racaniello, V.R.; Skalka, A.M. Principles of Virology, 3rd ed.; American Society for Microbiology Press: Washington, DC, USA, 2009.
5. Smith, J.A.; Daniel, R. Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses. ACS Chem. Biol. 2006, 1, 217-226.
6. Vandegraaff, N.; Engelman, A. Molecular mechanisms of HIV integration and therapeutic intervention. Expert Rev. Mol. Med. 2007, 9, 1-19.
7. Delelis, O.; Carayon, K.; Saib, A.; Deprez, E.; Mouscadet, J.F. Integrase and integration: biochemical activities of HIV-1 integrase. Retrovirology 2008, 5, 114.
8. Jaskolski, M.; Alexandratos, J.N.; Bujacz, G.; Wlodawer, A. Piecing together the structure of retroviral integrase, an important target in AIDS therapy. FEBS J. 2009, 276, 2926-2946.
9. Ceccherini-Silberstein, F.; Malet, I.; D'Arrigo, R.; Antinori, A.; Marcelin, A.G.; Perno, C.F. Characterization and structural analysis of HIV-1 integrase conservation. AIDS Rev. 2009, 11, 17-29.
10. McKee, C.J.; Kessl, J.J.; Shkriabai, N.; Dar, M.J.; Engelman, A.; Kvaratskhelia, M. Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein. J. Biol. Chem. 2008, 283, 31802-31812.
11. Lesbats, P.; Metifiot, M.; Calmels, C.; Baranova, S.; Nevinsky, G.; Andreola, M.L.; Parissi, V. In vitro initial attachment of HIV-1 integrase to viral ends: control of the DNA specific interaction by the oligomerization state. Nucleic Acids Res. 2008, 36, 7043-7058.
12. Hare, S.; Di Nunzio, F.; Labeja, A.; Wang, J.; Engelman, A.; Cherepanov, P. Structural basis for functional tetramerization of lentiviral integrase. PLoS Pathog. 2009, 5, e1000515:1-e1000515:15.
13. Michel, F.; Crucifix, C.; Granger, F.; Eiler, S.; Mouscadet, J.F.; Korolev, S.; Agapkina, J.; Ziganshin, R.; Gottikh, M.; Nazabal, A.; Emiliani, S.; Benarous, R.; Moras, D.; Schultz, P.; Ruff, M. Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor. Embo J. 2009, 28, 980-991.
14. Hare, S.; Cherepanov, P.; Wang, J. Application of general formulas for the correction of a lattice-translocation defect in crystals of a lentiviral integrase in complex with LEDGF. Acta Crystallogr. D. Biol. Crystallogr. 2009, 65, 966-973.
15. Wu, Y. HIV-1 gene expression: lessons from provirus and non-integrated DNA. Retrovirology 2004, 1, 13.
16. Wu, Y. The second chance story of HIV-1 DNA: Unintegrated? Not a problem! Retrovirology 2008, 5, 61.
17. Iyer, S.R.; Yu, D.; Biancotto, A.; Margolis, L.B.; Wu, Y. Measurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates. J. Virol. 2009, 83, 8662-8673.
18. Thomas, J.A.; Ott, D.E.; Gorelick, R.J. Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions. J. Virol. 2007, 81, 4367-4370.
19. Albanese, A.; Arosio, D.; Terreni, M.; Cereseto, A. HIV-1 pre-integration complexes selectively target decondensed chromatin in the nuclear periphery. PLoS ONE 2008, 3, e2413:1-e2413:9.
20. Christ, F.; Thys, W.; De Rijck, J.; Gijsbers, R.; Albanese, A.; Arosio, D.; Emiliani, S.; Rain, J.C.; Benarous, R.; Cereseto, A.; Debyser, Z. Transportin-SR2 imports HIV into the nucleus. Curr. Biol. 2008, 18, 1192-1202.
21. Jordan, A.; Defechereux, P.; Verdin, E. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. Embo J. 2001, 20, 1726-1738.
22. Jordan, A.; Bisgrove, D.; Verdin, E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. Embo J. 2003, 22, 1868-1877.
23. Lewinski, M.K.; Bisgrove, D.; Shinn, P.; Chen, H.; Hoffmann, C.; Hannenhalli, S.; Verdin, E.; Berry, C.C.; Ecker, J.R.; Bushman, F.D. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol. 2005, 79, 6610-6619.
24. Han, Y.; Lin, Y.B.; An, W.; Xu, J.; Yang, H.C.; O'Connell, K.; Dordai, D.; Boeke, J.D.; Siliciano, J.D.; Siliciano, R.F. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe 2008, 4, 134-146.
25. Bushman, F.D. Lateral DNA Transfer: Mechanisms and Consequences; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 2001.
26. Voigt, K.; Izsvak, Z.; Ivics, Z. Targeted gene insertion for molecular medicine. J. Mol. Med. 2008, 86, 1205-1219.
27. Nienhuis, A.W.; Dunbar, C.E.; Sorrentino, B.P. Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther. 2006, 13, 1031-1049.
28. Bushman, F.D. Retroviral integration and human gene therapy. J. Clin. Invest. 2007, 117, 2083-2086.
29. Pike-Overzet, K.; van der Burg, M.; Wagemaker, G.; van Dongen, J.J.; Staal, F.J. New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. Mol. Ther. 2007, 15, 1910-1916.
30. Cavazzana-Calvo, M.; Fischer, A. Gene therapy for severe combined immunodeficiency: are we there yet? J. Clin. Invest. 2007, 117, 1456-1465.
31. Kimmelman, J. The ethics of human gene transfer. Nat. Rev. Genet. 2008, 9, 239-244.
32. Ciuffi, A. Mechanisms governing lentivirus integration site selection. Curr. Gene Ther. 2008, 8, 419-429.
33. Hacein-Bey-Abina, S.; von Kalle, C.; Schmidt, M.; Le Deist, F.; Wulffraat, N.; McIntyre, E.; Radford, I.; Villeval, J.L.; Fraser, C.C.; Cavazzana-Calvo, M.; Fischer, A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 2003, 348, 255-256.
34. Hacein-Bey-Abina, S.; Garrigue, A.; Wang, G.P.; Soulier, J.; Lim, A.; Morillon, E.; Clappier, E.; Caccavelli, L.; Delabesse, E.; Beldjord, K.; Asnafi, V.; MacIntyre, E.; Dal Cortivo, L.; Radford, I.; Brousse, N.; Sigaux, F.; Moshous, D.; Hauer, J.; Borkhardt, A.; Belohradsky, B.H.; Wintergerst, U.; Velez, M.C.; Leiva, L.; Sorensen, R.; Wulffraat, N.; Blanche, S.; Bushman, F.D.; Fischer, A.; Cavazzana-Calvo, M. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 2008, 118, 3132-3142.
35. Wang, G.P.; Garrigue, A.; Ciuffi, A.; Ronen, K.; Leipzig, J.; Berry, C.; Lagresle-Peyrou, C.; Benjelloun, F.; Hacein-Bey-Abina, S.; Fischer, A.; Cavazzana-Calvo, M.; Bushman, F.D. DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer. Nucleic Acids Res. 2008, 36, e49:1-e49:12.
36. Wang, G.P.; Levine, B.L.; Binder, G.K.; Berry, C.C.; Malani, N.; McGarrity, G.; Tebas, P.; June, C.H.; Bushman, F.D. Analysis of Lentiviral Vector Integration in HIV+ Study Subjects Receiving Autologous Infusions of Gene Modified CD4+ T Cells. Mol. Ther. 2009, 17, 844-850.
37. Montini, E.; Cesana, D.; Schmidt, M.; Sanvito, F.; Bartholomae, C.C.; Ranzani, M.; Benedicenti, F.; Sergi, L.S.; Ambrosi, A.; Ponzoni, M.; Doglioni, C.; Di Serio, C.; von Kalle, C.; Naldini, L. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J. Clin. Invest. 2009, 119, 964-975.
38. Bushman, F.D.; Fujiwara, T.; Craigie, R. Retroviral DNA integration directed by HIV integration protein in vitro. Science 1990, 249, 1555-1558.
39. Chow, S.A. In vitro assays for activities of retroviral integrase. Methods 1997, 12, 306-317.
40. Sinha, S.; Pursley, M.H.; Grandgenett, D.P. Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors. J. Virol. 2002, 76, 3105-3113.
41. Sinha, S.; Grandgenett, D.P. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells. J. Virol. 2005, 79, 8208-8216.
42. Bushman, F.D.; Craigie, R. Sequence requirements for integration of Moloney murine leukemia virus DNA in vitro. J. Virol. 1990, 64, 5645-5648.
43. Leavitt, A.D.; Rose, R.B.; Varmus, H.E. Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae. J. Virol. 1992, 66, 2359-2368.
44. Pryciak, P.M.; Muller, H.P.; Varmus, H.E. Simian virus 40 minichromosomes as targets for retroviral integration in vivo. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 9237-9241.
45. Pryciak, P.M.; Sil, A.; Varmus, H.E. Retroviral integration into minichromosomes in vitro. Embo J. 1992, 11, 291-303.
46. Pryciak, P.M.; Varmus, H.E. Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 1992, 69, 769-780.
47. Bor, Y.C.; Bushman, F.D.; Orgel, L.E. In vitro integration of human immunodeficiency virus type 1 cDNA into targets containing protein-induced bends. Proc. Natl. Acad. Sci. USA 1995, 92, 10334-10338.
48. Stevens, S.W.; Griffith, J.D. Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration. J. Virol. 1996, 70, 6459-6462.
49. Bor, Y.C.; Miller, M.D.; Bushman, F.D.; Orgel, L.E. Target-sequence preferences of HIV-1 integration complexes in vitro. Virology 1996, 222, 283-288.
50. Muller, H.P.; Varmus, H.E. DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. Embo J. 1994, 13, 4704-4714.
51. Pruss, D.; Bushman, F.D.; Wolffe, A.P. Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc. Natl. Acad. Sci. USA 1994, 91, 5913-5917.
52. Pruss, D.; Reeves, R.; Bushman, F.D.; Wolffe, A.P. The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J. Biol. Chem. 1994, 269, 25031-25041.
53. Botbol, Y.; Raghavendra, N.K.; Rahman, S.; Engelman, A.; Lavigne, M. Chromatinized templates reveal the requirement for the LEDGF/p75 PWWP domain during HIV-1 integration in vitro. Nucleic Acids Res. 2008, 36, 1237-1246.
54. Bushman, F.D. Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc. Natl. Acad. Sci. USA 1994, 91, 9233-9237.
55. Goulaouic, H.; Chow, S.A. Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein. J. Virol. 1996, 70, 37-46.
56. Tan, W.; Zhu, K.; Segal, D.J.; Barbas, C.F., 3rd; Chow, S.A. Fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc finger protein E2C direct integration of viral DNA into specific sites. J. Virol. 2004, 78, 1301-1313.
57. Bushman, F.; Lewinski, M.; Ciuffi, A.; Barr, S.; Leipzig, J.; Hannenhalli, S.; Hoffmann, C. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 2005, 3, 848-858.
58. Ciuffi, A.; Ronen, K.; Brady, T.; Malani, N.; Wang, G.; Berry, C.C.; Bushman, F.D. Methods for integration site distribution analyses in animal cell genomes. Methods 2009, 47, 261-268.
59. Schroder, A.R.; Shinn, P.; Chen, H.; Berry, C.; Ecker, J.R.; Bushman, F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002, 110, 521-529.
60. Wu, X.; Li, Y.; Crise, B.; Burgess, S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003, 300, 1749-1751.
61. Craigie, R.; Fujiwara, T.; Bushman, F. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 1990, 62, 829-837.
62. Mitchell, R.S.; Beitzel, B.F.; Schroder, A.R.; Shinn, P.; Chen, H.; Berry, C.C.; Ecker, J.R.; Bushman, F.D. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2004, 2, e234:1127-e234:1137.
63. Ciuffi, A.; Llano, M.; Poeschla, E.; Hoffmann, C.; Leipzig, J.; Shinn, P.; Ecker, J.R.; Bushman, F. A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 2005, 11, 1287-1289.
64. Ciuffi, A.; Mitchell, R.S.; Hoffmann, C.; Leipzig, J.; Shinn, P.; Ecker, J.R.; Bushman, F.D. Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. Mol. Ther. 2006, 13, 366-373.
65. Trobridge, G.D.; Miller, D.G.; Jacobs, M.A.; Allen, J.M.; Kiem, H.P.; Kaul, R.; Russell, D.W. Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. USA 2006, 103, 1498-1503.
66. Lewinski, M.K.; Yamashita, M.; Emerman, M.; Ciuffi, A.; Marshall, H.; Crawford, G.; Collins, F.; Shinn, P.; Leipzig, J.; Hannenhalli, S.; Berry, C.C.; Ecker, J.R.; Bushman, F.D. Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2006, 2, e60:611-e60:622.
67. Barr, S.D.; Ciuffi, A.; Leipzig, J.; Shinn, P.; Ecker, J.R.; Bushman, F.D. HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. Mol. Ther. 2006, 14, 218-225.
68. Levine, B.L.; Humeau, L.M.; Boyer, J.; MacGregor, R.R.; Rebello, T.; Lu, X.; Binder, G.K.; Slepushkin, V.; Lemiale, F.; Mascola, J.R.; Bushman, F.D.; Dropulic, B.; June, C.H. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. USA 2006, 103, 17372-17377.
69. Hacker, C.V.; Vink, C.A.; Wardell, T.W.; Lee, S.; Treasure, P.; Kingsman, S.M.; Mitrophanous, K.A.; Miskin, J.E. The integration profile of EIAV-based vectors. Mol. Ther. 2006, 14, 536-545.
70. Nowrouzi, A.; Dittrich, M.; Klanke, C.; Heinkelein, M.; Rammling, M.; Dandekar, T.; von Kalle, C.; Rethwilm, A. Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol. 2006, 87, 1339-1347.
71. Kim, S.; Kim, Y.; Liang, T.; Sinsheimer, J.S.; Chow, S.A. A high-throughput method for cloning and sequencing human immunodeficiency virus type 1 integration sites. J. Virol. 2006, 80, 11313-11321.
72. Wang, G.P.; Ciuffi, A.; Leipzig, J.; Berry, C.C.; Bushman, F.D. HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 2007, 17, 1186-1194.
73. Felice, B.; Cattoglio, C.; Cittaro, D.; Testa, A.; Miccio, A.; Ferrari, G.; Luzi, L.; Recchia, A.; Mavilio, F. Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. PLoS ONE 2009, 4, e4571:1-e4571:16.
74. Wellensiek, B.P.; Ramakrishnan, R.; Sundaravaradan, V.; Mehta, R.; Harris, D.T.; Ahmad, N. Differential HIV-1 integration targets more actively transcribed host genes in neonatal than adult blood mononuclear cells. Virology 2009, 385, 28-38.
75. Vatakis, D.N.; Kim, S.; Kim, N.; Chow, S.A.; Zack, J.A. Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells. J. Virol. 2009, 83, 6222-6233.
76. Brady, T.; Agosto, L.M.; Malani, N.; Berry, C.C.; O'Doherty, U.; Bushman, F. HIV integration site distributions in resting and activated CD4+ T cells infected in culture. Aids 2009, 23, 1461-1471.
77. Barr, S.D.; Leipzig, J.; Shinn, P.; Ecker, J.R.; Bushman, F.D. Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome. J. Virol. 2005, 79, 12035-12044.
78. Beard, B.C.; Keyser, K.A.; Trobridge, G.D.; Peterson, L.J.; Miller, D.G.; Jacobs, M.; Kaul, R.; Kiem, H.P. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus. Hum. Gene Ther. 2007, 18, 423-434.
79. Beard, B.C.; Dickerson, D.; Beebe, K.; Gooch, C.; Fletcher, J.; Okbinoglu, T.; Miller, D.G.; Jacobs, M.A.; Kaul, R.; Kiem, H.P.; Trobridge, G.D. Comparison of HIV-derived Lentiviral and MLV-based Gammaretroviral Vector Integration Sites in Primate Repopulating Cells. Mol. Ther. 2007, 15, 1356-1365.
80. Shun, M.C.; Raghavendra, N.K.; Vandegraaff, N.; Daigle, J.E.; Hughes, S.; Kellam, P.; Cherepanov, P.; Engelman, A. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev. 2007, 21, 1767-1778.
81. Marshall, H.M.; Ronen, K.; Berry, C.; Llano, M.; Sutherland, H.; Saenz, D.; Bickmore, W.; Poeschla, E.; Bushman, F.D. Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting. PLoS ONE 2007, 2, e1340:1-e1340:13.
82. MacNeil, A.; Sankale, J.L.; Meloni, S.T.; Sarr, A.D.; Mboup, S.; Kanki, P. Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo. J. Virol. 2006, 80, 7316-7321.
83. Crise, B.; Li, Y.; Yuan, C.; Morcock, D.R.; Whitby, D.; Munroe, D.J.; Arthur, L.O.; Wu, X. Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1. J. Virol. 2005, 79, 12199-12204.
84. Hematti, P.; Hong, B.K.; Ferguson, C.; Adler, R.; Hanawa, H.; Sellers, S.; Holt, I.E.; Eckfeldt, C.E.; Sharma, Y.; Schmidt, M.; von Kalle, C.; Persons, D.A.; Billings, E.M.; Verfaillie, C.M.; Nienhuis, A.W.; Wolfsberg, T.G.; Dunbar, C.E.; Calmels, B. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2004, 2, e423:1-e423:8.
85. Kang, Y.; Moressi, C.J.; Scheetz, T.E.; Xie, L.; Tran, D.T.; Casavant, T.L.; Ak, P.; Benham, C.J.; Davidson, B.L.; McCray, P.B., Jr. Integration site choice of a feline immunodeficiency virus vector. J. Virol. 2006, 80, 8820-8823.
86. Narezkina, A.; Taganov, K.D.; Litwin, S.; Stoyanova, R.; Hayashi, J.; Seeger, C.; Skalka, A.M.; Katz, R.A. Genome-wide analyses of avian sarcoma virus integration sites. J. Virol. 2004, 78, 11656-11663.
87. Faschinger, A.; Rouault, F.; Sollner, J.; Lukas, A.; Salmons, B.; Gunzburg, W.H.; Indik, S. Mouse Mammary Tumor Virus Integration Site Selection in Human and Mouse Genomes. J. Virol. 2008, 83, 1360-1367.
88. Brady, T.; Lee, Y.N.; Ronen, K.; Malani, N.; Berry, C.C.; Bieniasz, P.D.; Bushman, F.D. Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev. 2009, 23, 633-642.
89. Aker, M.; Tubb, J.; Miller, D.G.; Stamatoyannopoulos, G.; Emery, D.W. Integration bias of gammaretrovirus vectors following transduction and growth of primary mouse hematopoietic progenitor cells with and without selection. Mol. Ther. 2006, 14, 226-235.
90. Moalic, Y.; Blanchard, Y.; Felix, H.; Jestin, A. Porcine endogenous retrovirus integration sites in the human genome: features in common with those of murine leukemia virus. J. Virol. 2006, 80, 10980-10988.
91. Moalic, Y.; Felix, H.; Takeuchi, Y.; Jestin, A.; Blanchard, Y. Genome areas with high gene density and CpG island neighborhood strongly attract porcine endogenous retrovirus for integration and favor the formation of hot spots. J. Virol. 2009, 83, 1920-1929.
92. Kim, S.; Kim, N.; Dong, B.; Boren, D.; Lee, S.A.; Das Gupta, J.; Gaughan, C.; Klein, E.A.; Lee, C.; Silverman, R.H.; Chow, S.A. Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J. Virol. 2008, 82, 9964-9977.
93. Doi, K.; Wu, X.; Taniguchi, Y.; Yasunaga, J.; Satou, Y.; Okayama, A.; Nosaka, K.; Matsuoka, M. Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states. Blood 2005, 106, 1048-1053.
94. Derse, D.; Crise, B.; Li, Y.; Princler, G.; Lum, N.; Stewart, C.; McGrath, C.F.; Hughes, S.H.; Munroe, D.J.; Wu, X. Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J. Virol. 2007, 81, 6731-6741.
95. Meekings, K.N.; Leipzig, J.; Bushman, F.D.; Taylor, G.P.; Bangham, C.R. HTLV-1 Integration into Transcriptionally Active Genomic Regions Is Associated with Proviral Expression and with HAM/TSP. PLoS Pathog. 2008, 4, e1000027:1-e1000027:10.
96. Carteau, S.; Hoffmann, C.; Bushman, F. Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target. J. Virol. 1998, 72, 4005-4014.
97. Holman, A.G.; Coffin, J.M. Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc. Natl. Acad. Sci. USA 2005, 102, 6103-6107.
98. Berry, C.; Hannenhalli, S.; Leipzig, J.; Bushman, F.D. Selection of target sites for mobile DNA integration in the human genome. PLoS Comput. Biol. 2006, 2, e157:1450-e157:1462.
99. Shun, M.C.; Daigle, J.E.; Vandegraaff, N.; Engelman, A. Wild-type levels of human immunodeficiency virus type 1 infectivity in the absence of cellular emerin protein. J. Virol. 2007, 81, 166-172.
100. Segal, E.; Fondufe-Mittendorf, Y.; Chen, L.; Thastrom, A.; Field, Y.; Moore, I.K.; Wang, J.P.; Widom, J. A genomic code for nucleosome positioning. Nature 2006, 442, 772-778.
101. Crawford, G.E.; Holt, I.E.; Whittle, J.; Webb, B.D.; Tai, D.; Davis, S.; Margulies, E.H.; Chen, Y.; Bernat, J.A.; Ginsburg, D.; Zhou, D.; Luo, S.; Vasicek, T.J.; Daly, M.J.; Wolfsberg, T.G.; Collins, F.S. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res. 2006, 16, 123-131.
102. Tobaly-Tapiero, J.; Bittoun, P.; Lehmann-Che, J.; Delelis, O.; Giron, M.L.; de The, H.; Saib, A. Chromatin tethering of incoming foamy virus by the structural Gag protein. Traffic 2008, 9, 1717-1727.
103. Bushman, F.D. Integration site selection by lentiviruses: biology and possible control. Curr. Top. Microbiol. Immunol. 2002, 261, 165-177.
104. Engelman, A. The roles of cellular factors in retroviral integration. Curr. Top. Microbiol. Immunol. 2003, 281, 209-238.
105. Van Maele, B.; Debyser, Z. HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins. AIDS Rev. 2005, 7, 26-43.
106. Van Maele, B.; Busschots, K.; Vandekerckhove, L.; Christ, F.; Debyser, Z. Cellular co-factors of HIV-1 integration. Trends Biochem. Sci. 2006, 31, 98-105.
107. Al-Mawsawi, L.Q.; Neamati, N. Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy. Trends Pharmacol. Sci. 2007, 28, 526-535.
108. Bushman, F.D.; Malani, N.; Fernandes, J.; D'Orso, I.; Cagney, G.; Diamond, T.L.; Zhou, H.; Hazuda, D.J.; Espeseth, A.S.; Konig, R.; Bandyopadhyay, S.; Ideker, T.; Goff, S.P.; Krogan, N.J.; Frankel, A.D.; Young, J.A.; Chanda, S.K. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 2009, 5, e1000437:1-e1000437:12.
109. Ciuffi, A.; Bushman, F.D. Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet. 2006, 22, 388-395.
110. Engelman, A.; Cherepanov, P. The Lentiviral Integrase Binding Protein LEDGF/p75 and HIV-1 Replication. PLoS Pathog. 2008, 4, e1000046:1-e1000046:9.
111. Poeschla, E.M. Integrase, LEDGF/p75 and HIV replication. Cell. Mol. Life Sci. 2008, 65, 1403-1424.
112. Cherepanov, P.; Ambrosio, A.L.; Rahman, S.; Ellenberger, T.; Engelman, A. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl. Acad. Sci. USA 2005, 102, 17308-17313.
113. Ge, H.; Si, Y.; Roeder, R.G. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. Embo J. 1998, 17, 6723-6729.
114. Ganapathy, V.; Daniels, T.; Casiano, C.A. LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis. Autoimmun. Rev. 2003, 2, 290-297.
115. Shinohara, T.; Singh, D.P.; Fatma, N. LEDGF, a survival factor, activates stress-related genes. Prog. Retin. Eye Res. 2002, 21, 341-358.
116. Sutherland, H.G.; Newton, K.; Brownstein, D.G.; Holmes, M.C.; Kress, C.; Semple, C.A.; Bickmore, W.A. Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations. Mol. Cell. Biol. 2006, 26, 7201-7210.
117. Llano, M.; Saenz, D.T.; Meehan, A.; Wongthida, P.; Peretz, M.; Walker, W.H.; Teo, W.; Poeschla, E.M. An essential role for LEDGF/p75 in HIV integration. Science 2006, 314, 461-464.
118. Vandekerckhove, L.; Christ, F.; Van Maele, B.; De Rijck, J.; Gijsbers, R.; Van den Haute, C.; Witvrouw, M.; Debyser, Z. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J. Virol. 2006, 80, 1886-1896.
119. De Rijck, J. and Debyser, Z. KU Leuven, Leuven, Belgium. Personal communication, 2009.
120. Desfarges, S.; Munoz, M.; Leleu, M.; Lefebvre, G.; Rougemont, J.; Xenarios, I.; Ciuffi, A. Analysis of LEDGF/p75-bound sequences by ChIP-Seq. Genome Res., to be submitted for publication.
121. Ciuffi, A.; Diamond, T.L.; Hwang, Y.; Marshall, H.M.; Bushman, F.D. Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor. Hum. Gene Ther. 2006, 17, 960-967.
122. Meehan, A.M.; Saenz, D.T.; Morrison, J.H.; Garcia-Rivera, J.A.; Peretz, M.; Llano, M.; Poeschla, E.M. LEDGF/p75 proteins with alternative chromatin tethers are functional HIV-1 cofactors. PLoS Pathog. 2009, 5, e1000522:1-e1000522:18.
123. Silvers, R.; Smith, J.A.; Schowalter, M.; Litwin, S.; Liang, Z.; Geary, K.; Daniel, R. Modification of Integration Site Preferences of an HIV-1-based Vector by expression of a novel synthetic protein. Hum. Gene Ther. 2009, doi:10.1089/hum.2009.134.
124. Gijsbers, R.; Ronen, K.; Vets, S.; Malani, N.; De Rijck, J.; McNeely, M.; Bushman, F.D.; Debyser, Z. LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol. Ther. 2010, in press.
125. Studamire, B.; Goff, S.P. Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors. Retrovirology 2008, 5, 48.
126. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004, 306, 636-640.
127. Consortium, T.E.P. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447, 799-816.
128. Yokoyama, A.; Cleary, M.L. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 2008, 14, 36-46.
129. Ge, H.; Roeder, R.G. Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes. Cell 1994, 78, 513-523.
130. Roeder, R.G. The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem. Sci. 1996, 21, 327-335.
131. Fukuda, A.; Nakadai, T.; Shimada, M.; Tsukui, T.; Matsumoto, M.; Nogi, Y.; Meisterernst, M.; Hisatake, K. Transcriptional coactivator PC4 stimulates promoter escape and facilitates transcriptional synergy by GAL4-VP16. Mol. Cell. Biol. 2004, 24, 6525-6535.
132. Calvo, O.; Manley, J.L. The transcriptional coactivator PC4/Sub1 has multiple functions in RNA polymerase II transcription. Embo J. 2005, 24, 1009-1020.